Are you Dr. Oldham?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 86 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1701 Thomson Dr
Suite 200
Lynchburg, VA 24501Phone+1 434-200-5925Fax+1 434-200-6254
Summary
- Dr. Dwight Oldham, MD is an oncologist in Lynchburg, Virginia. He is currently licensed to practice medicine in Virginia. He is affiliated with Centra Lynchburg General Hospital.
Education & Training
- Virginia Commonwealth University Health SystemResidency, Internal Medicine, 1976 - 1981
- Virginia Commonwealth University School of MedicineClass of 1976
Certifications & Licensure
- VA State Medical License 1977 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Medical Oncology EMR, Varian Medical Systems, 2013
Clinical Trials
- NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
- PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
- Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer Start of enrollment: 2013 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 32 citationsAssociation of 70-Gene Signature Assay Findings With Physicians' Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gen...Michaela Tsai, Shelly S. Lo, William Audeh, Rubina Qamar, Raye Budway
JAMA Oncology. 2018-01-11 - 1 citationsRe: Using the 21‐gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):91...Harry D. Bear, Wen Wan, André Robidoux, Peter Rubin, Steven Limentani
Journal of Surgical Oncology. 2017-07-28 - 69 citationsUsing the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial.Harry D. Bear, Wen Wan, André Robidoux, Peter Rubin, Steven Limentani
Journal of Surgical Oncology. 2017-06-01